Lymph node-targeting nanovaccines for cancer immunotherapy.
Wang Q, Wang Z, Sun X, Jiang Q, Sun B, He Z, Zhang S, Luo C, Sun J.
Wang Q, et al. Among authors: sun b, sun j, sun x.
J Control Release. 2022 Nov;351:102-122. doi: 10.1016/j.jconrel.2022.09.015. Epub 2022 Sep 20.
J Control Release. 2022.
PMID: 36115556
Review.